Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Menkes Disease Mutations And Response To Early Copper Histidine Treatment
Published 1996 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
This paper references
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.
M. Kozak (1987)
Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production.
A. Winnard (1995)
Early copper-histidine treatment for Menkes disease
Z. Tümer (1996)
Successful early copper therapy in Menkes disease associated with a mutant transcript containing a small In-frame deletion.
S. Kaler (1996)
Early copper therapy in classic Menkes disease patients with a novel splicing mutation
S. Kaler (1995)
Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions.
K. Petrukhin (1994)
Requirements for intercistronic distance and level of eukaryotic initiation factor 2 activity in reinitiation on GCN4 mRNA vary with the downstream cistron.
C. M. Grant (1994)
This paper is referenced by
The molecular mechanisms of copper metabolism and its roles in human diseases
J. Chen (2020)
Safety of intracerebroventricular copper histidine in adult rats.
K. Lem (2007)
Catecholamine metabolites affected by the copper-dependent enzyme dopamine-beta-hydroxylase provide sensitive biomarkers for early diagnosis of menkes disease and viral-mediated ATP7A gene therapy.
S. Kaler (2013)
Astroglia as metal depots: molecular mechanisms for metal accumulation, storage and release.
E. Tiffany-Castiglion (2001)
Copper-regulated Trafficking of the Menkes Disease Copper ATPase Is Associated with Formation of a Phosphorylated Catalytic Intermediate*
M. Petris (2002)
Neonatal diagnosis and treatment of Menkes disease.
Stephen G. Kaler (2008)
Risk-benefit analysis of mineral intakes: case studies on copper and iron.
S. Fairweather-Tait (2011)
Tandem Duplication of Exons 1-7 Neither Impairs ATP7A Expression Nor Causes a Menkes Disease Phenotype.
Eun-Young Choi (2015)
Copper‐replacement treatment for symptomatic Menkes disease: ethical considerations
S. R. Sheela (2005)
Diagnosis and therapy of Menkes syndrome , a genetic form of copper deficiency 1 , 2
S. Kaler ()
Modulating copper metabolism as a strategy to treat neurodegenerative tauopathies
S. McKenzie-Nickson (2017)
13 novel putative mutations in ATP7A found in a cohort of 25 Italian families
Paola de Gemmis (2017)
Defective copper-induced trafficking and localization of the Menkes protein in patients with mild and copper-treated classical Menkes disease.
L. Ambrosini (1999)
Dopamine beta-hydroxylase deficiency associated with mutations in a copper transporter gene.
S. Kaler (1998)
Prenatal diagnosis of Menkes disease
S. Kaler (1998)
Early copper histidine therapy in classic menkes disease
B. Sarkar (1997)
Copper comes of age in Melbourne.
J. Mercer (2016)
Late‐onset treatment in Menkes disease: is there a correlation between genotype and response to therapy?
J. L. Olivares (2006)
In utero copper treatment for Menkes disease associated with a severe ATP7A mutation.
Marie Reine Haddad (2012)
Molecular basis of the brindled mouse mutant (Mo(br)): a murine model of Menkes disease.
A. Grimes (1997)
Evidence that translation reinitiation leads to a partially functional Menkes protein containing two copper-binding sites.
M. Paulsen (2006)
Changes in body weight and height in survivors of Menkes disease.
Y. Gu (2014)
Functional Expression of the Menkes Disease Protein Reveals Common Biochemical Mechanisms Among the Copper-transporting P-type ATPases*
A. Payne (1998)
ATP‐dependent copper transport by the Menkes protein in membrane vesicles isolated from cultured Chinese hamster ovary cells
I. Voskoboinik (1998)
Catecholamine Phenotyping: Clues to the Diagnosis, Treatment, and Pathophysiology of Neurogenetic Disorders
D. Goldstein (1996)
Molecular Basis of Diseases of Copper Homeostasis
J. Mercer (2002)
Functional expression of the Wilson disease protein reveals mislocalization and impaired copper-dependent trafficking of the common H1069Q mutation.
A. Payne (1998)
Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation.
O. I. Buiakova (1999)
Epilepsy in Menkes disease: An electroclinical long-term study of 28 patients
A. Verrotti (2014)
Internal jugular phlebectasia in Menkes disease.
D. J. Price (2007)
Translational read‐through of a nonsense mutation in ATP7A impacts treatment outcome in Menkes disease
S. Kaler (2009)
Role of copper in human neurological disorders 1 – 3
V. Desai (2008)See more